首页> 外国专利> HUMAN BRAIN ENDOTHELIAL CELLS AND GROWTH MEDIUM AND METHOD FOR EXPANSION OF PRIMITIVE CD34+CD38 - BONE MARROW STEM CELLS

HUMAN BRAIN ENDOTHELIAL CELLS AND GROWTH MEDIUM AND METHOD FOR EXPANSION OF PRIMITIVE CD34+CD38 - BONE MARROW STEM CELLS

机译:人脑内皮细胞和生长培养基及原代CD34 + CD38-骨髓基质干细胞的扩增方法

摘要

A novel co-culture system using human brain endothelial cells (HUBEC) which promotes the expansion of human CD34+CD38- cells consistent with the PMVEC system is disclosed. HUBEC were isolated from cadaveric donors, passed in primary culture, cloned and found to be Von Willebrand Factor positive. Cultivation of purified bone marrow CD34+ cells on HUBEC monolayers supplemented with GM-CSF+IL-3+IL-6+SCF+flt-3 ligand caused a 14.5-fold increase in total cells, an 6.6-fold increase in CD34+ cells, and, most remarkably, a 440-fold increase in CD34+CD38- cells after 7 days. Further, CFU-GM production increased 15.1-fold, BFU-E increased 8-fold, and CFU-Mix increased 5.2-fold. Optimal generation was dependent upon the continued presence of exogenous supplied cytokines. Moreover, we found that non-brain human endothelial cells isolated from the same donors supported neither the expansion nor the maintenance of human CD34+CD38- cells.
机译:公开了使用人脑内皮细胞(HUBEC)的新型共培养系统,其促进了与PMVEC系统一致的人CD34 + CD38-细胞的扩增。从尸体供体中分离出HUBEC,在原代培养中进行传代,克隆后发现其为Von Willebrand因子阳性。在补充了GM-CSF + IL-3 + IL-6 + SCF + flt-3配体的HUBEC单层上培养纯化的骨髓CD34 +细胞导致总细胞增加14.5倍,其中CD34增加6.6倍+细胞,最显着的是7天后CD34 + CD38-细胞增加440倍。此外,CFU-GM产量增加了15.1倍,BFU-E增加了8倍,CFU-Mix增加了5.2倍。最佳产生取决于外源提供的细胞因子的持续存在。此外,我们发现从相同供体分离的非脑人内皮细胞既不支持人CD34 + CD38-细胞的扩增,也不支持其维持。

著录项

  • 公开/公告号IL175471D0

    专利类型

  • 公开/公告日2006-09-05

    原文格式PDF

  • 申请/专利权人 NAVAL MEDICAL RESEARCH CENTER;

    申请/专利号IL20060175471

  • 发明设计人

    申请日2006-05-07

  • 分类号A61K35/12;A61K35/28;A61P7;A61P43;C12N5/0789;C12R1/91;

  • 国家 IL

  • 入库时间 2022-08-21 21:39:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号